RAYNHAM, Mass., Aug. 25, 2021 /PRNewswire/ -- The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, will feature new products and technology solutions shaping new standards of care for modern day orthopaedics during the American Academy of Orthopaedic Surgeons (AAOS) annual meeting Aug. 31–Sept. 3 in San Diego. From robotics and more personalized implants to connected instrumentation, advanced imaging and visualization technology, DePuy Synthes will showcase next generation product innovations spanning its VELYS™ Digital Surgery, Hip, Knee, Shoulder, Trauma and Extremities, Spine, Sports Medicine and Power Tools portfolios onsite at Booth #2935.
"We're excited to engage with the orthopaedic surgeon community at AAOS to address the new demands facing our industry for more personalized and integrated products and services that can enhance the overall surgical experience," said Aldo Denti, Company Group Chairman for DePuy Synthes***. "Even during the global pandemic, we've continued our pursuit of delivering advanced implants, digital solutions and technologies, and clinical and economic evidence to further advance the orthopaedic industry to the next level."
DePuy Synthes will feature more than 25 new products and technology solutions at AAOS, and offer immersive in-booth virtual reality experiences, as well as an Evidence Corner that will showcase the clinical and economic evidence supporting our products. Key product innovations and solutions to be featured are:
VELYS™ DIGITAL SURGERY
INHANCE™ SHOULDER SYSTEM
ATTUNE® Cementless Fixed Bearing Knee with AFFIXIUM™ 3DP Technology
PINNACLE® Dual Mobility Liner
ACTIS® Collarless Hip Stem
VELYS Hip Navigation 3.0
DYNATAPE™ Suture
† Benchtop and animal study data may not necessarily be indicative of clinical performance.
UNIUM™ Power System‡
‡Pending US product release. The safety and effectiveness of the product is not established. Not available for sale or commercial use.
ADDRESSING AMBULATORY SURGERY CENTERS (ASCs)
TRUMATCH® GRAFT CAGE – LONG BONE AND RIA 2 SYSTEM
SYMPHONY™ OCT System
For more information about DePuy Synthes and these products, visit our digital newsroom.
About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people's healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
About DePuy Synthes
DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.depuysynthes.com.
* Comprising the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson's Medical Devices segment.
** DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
*** Aldo Denti is an employee of Medical Device Business Services, Inc.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding DePuy Synthes products. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Synthes, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2021, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in the company's most recently filed Quarterly Report on Form 10-Q, and the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither the Johnson & Johnson Medical Devices Companies nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.
[1] DePuy Synthes. Rationale for height specification of 3DP surface texture. 27 June 2019. SEA 103522524.
[2] Kane, R; Miltner, N; Smith, B; Tong, W; Initial mechanical stability of additively manufactured pegs in cancellous bone, ORS 2020, Poster # 1772.
[3] W. Tong, B. Smith, et al. Bone ingrowth of RTT porous structure, ORS 2020 Poster # 0337
[4] W. Tong, B. English, C. Henderson, R. Kane, B. Smith. RTT Cancellous Bone Ingrowth And Pore Morphometrics, ORS 2021, Poster # 0410.
[5] DePuy Synthes PINNACLE Dual Mobility Jump Distance Assessment. 12/16/2019. ADAPTIV #103647144. Note: These values are an average based on stems run through the test protocol
[6] DePuy Synthes PINNACLE DM ROM Analysis. 12/10/2019. ADAPTIV #103642723. Note: These values are an average based on stems run through the test protocol.
[7] DePuy Synthes PINNACLE DM ROM Analysis All Stems. 3/27/2020. ADAPTIV #103676417. Note: These values are an average based on stems run through the test protocol.
[8] Hamburg University ACTIS Cadaveric Stability Testing. (Adaptiv #103156243).
[9] DePuy Synthes Worldwide VHN Case Report. 2018 – 2021.
[10] DePuy Synthes DYNATAPE™ Suture Approximation Force Report. 3/13/2020. ADAPTIV #103670396.
[11] DePuy Synthes Power Tools. Design Validation Report 07/2021 Windchill Ref. #0000310897.
[12] DePuy Synthes Internal Engineering Report 07/2021 Windchill Ref. #0000312221.
[13] DePuy Synthes Power Tools. Internal Engineering Report 07/2021 Windchill Ref. #0000312309.
[14] DePuy Synthes Power Tools. Design Validation Report 07/2021 Windchill Ref. #0000310897.
[15] Dawson J, Kiner D, Gardner W, 2nd, Swafford R, Nowotarski PJ. The reamer-irrigator-aspirator as a device for harvesting bone graft compared with iliac crest bone graft: union rates and complications. J Orthop Trauma. 2014; 28(10):584--590.
[16] Henrich D, Seebach C, Sterlepper E, Tauchmann C, Marzi I, Frank J. RIA reamings and hip aspirate: a comparative evaluation of osteoprogenitor and endothelial progenitor cells. Injury. 2010; 41 Suppl 2:S62-68.
[17] Sagi HC, Young ML, Gerstenfield L, Einhorn TA, Tornetta P. Qualitative and quantitative differences between bone graft obtained from the medullary canal (with a reamer/irrigator/aspirator) and the iliac crest of the same patient. J Bone Joint Surg Am. 2012; 94(23):2128-2135.
[18] Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK , Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42-Suppl 2:S3-S15.
Media Contact:
Erin Walsh
ewalsh21@ITS.JNJ.com
Investor Contact:
Sarah Wood
SWood15@its.jnj.com
186658-210819 DSUS
© DePuy Synthes 2021. All rights reserved.
Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.
SOURCE DePuy Synthes